Who invested in SAB Biotherapeutics?
SAB Biotherapeutics's investors include RA Capital Management, Vivo Capital, Sanofi and RTW Investments LLC.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$85Mraised across 1 round since 2026, from 1 source
SAB Biotherapeutics's investors include RA Capital Management, Vivo Capital, Sanofi and RTW Investments LLC.
SAB Biotherapeutics has raised $85M across 1 round since 2026.
SAB Biotherapeutics's most recent round was an Undisclosed round of $85M in Mar 2026.
Its most recent round, $85M in Mar 2026, is also its largest on record.
SAB Biotherapeutics's first round on record, in Mar 2026, was backed by RA Capital Management, Vivo Capital and Sanofi and 1 others.
SAB Biotherapeutics's latest named round is an Undisclosed round, in Mar 2026.
SAB Biotherapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.